HEADER IMMUNE SYSTEM 14-OCT-20 7KFK TITLE CRYSTAL STRUCTURE OF LILRB1 D3D4 DOMAIN IN COMPLEX WITH PLASMODIUM TITLE 2 RIFIN (PF3D7_1373400) V2 DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOFORM 2 OF LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR COMPND 3 SUBFAMILY B MEMBER 1; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR 1,CD85 ANTIGEN-LIKE COMPND 6 FAMILY MEMBER J,IMMUNOGLOBULIN-LIKE TRANSCRIPT 2,ILT-2, COMPND 7 MONOCYTE/MACROPHAGE IMMUNOGLOBULIN-LIKE RECEPTOR 7,MIR-7; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: RIFIN; COMPND 11 CHAIN: E, C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LILRB1, ILT2, LIR1, MIR7; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM (ISOLATE 3D7); SOURCE 10 ORGANISM_TAXID: 36329; SOURCE 11 STRAIN: ISOLATE 3D7; SOURCE 12 GENE: PF3D7_1373400; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS LILRB1, RIFIN, MALARIA, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR K.XU,P.D.KWONG REVDAT 4 18-OCT-23 7KFK 1 REMARK REVDAT 3 05-MAY-21 7KFK 1 JRNL REVDAT 2 14-APR-21 7KFK 1 JRNL REVDAT 1 31-MAR-21 7KFK 0 JRNL AUTH Y.CHEN,K.XU,L.PICCOLI,M.FOGLIERINI,J.TAN,W.JIN,J.GORMAN, JRNL AUTH 2 Y.TSYBOVSKY,B.ZHANG,B.TRAORE,C.SILACCI-FREGNI, JRNL AUTH 3 C.DAUBENBERGER,P.D.CROMPTON,R.GEIGER,F.SALLUSTO,P.D.KWONG, JRNL AUTH 4 A.LANZAVECCHIA JRNL TITL STRUCTURAL BASIS OF MALARIA RIFIN BINDING BY JRNL TITL 2 LILRB1-CONTAINING ANTIBODIES. JRNL REF NATURE V. 592 639 2021 JRNL REFN ESSN 1476-4687 JRNL PMID 33790470 JRNL DOI 10.1038/S41586-021-03378-6 REMARK 2 REMARK 2 RESOLUTION. 2.63 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_3965 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.63 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.44 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 28615 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 1415 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 10.0000 - 5.6700 0.98 2908 144 0.2015 0.2089 REMARK 3 2 5.6700 - 4.5000 1.00 2758 162 0.1798 0.2224 REMARK 3 3 4.5000 - 3.9300 1.00 2763 136 0.1885 0.2298 REMARK 3 4 3.9300 - 3.5700 1.00 2732 147 0.2182 0.2714 REMARK 3 5 3.5700 - 3.3200 1.00 2728 128 0.2664 0.3587 REMARK 3 6 3.3200 - 3.1200 1.00 2712 148 0.2801 0.3355 REMARK 3 7 3.1200 - 2.9700 1.00 2698 141 0.2895 0.3696 REMARK 3 8 2.9700 - 2.8400 1.00 2686 144 0.2888 0.3706 REMARK 3 9 2.8400 - 2.7300 1.00 2677 140 0.3255 0.3924 REMARK 3 10 2.7300 - 2.6300 0.94 2538 125 0.3838 0.4425 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.450 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.480 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 64.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 2 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 222 THROUGH 275 OR REMARK 3 RESID 277 THROUGH 363 OR RESID 365 REMARK 3 THROUGH 369 OR RESID 371 THROUGH 401 OR REMARK 3 RESID 403 OR RESID 405 THROUGH 427 OR REMARK 3 RESID 1200)) REMARK 3 SELECTION : (CHAIN B AND (RESID 222 THROUGH 275 OR REMARK 3 RESID 277 THROUGH 363 OR RESID 365 REMARK 3 THROUGH 369 OR RESID 371 THROUGH 401 OR REMARK 3 RESID 403 OR RESID 405 THROUGH 427 OR REMARK 3 RESID 1200)) REMARK 3 ATOM PAIRS NUMBER : 1196 REMARK 3 RMSD : NULL REMARK 3 NCS GROUP : 2 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN C AND (RESID 184 OR RESID 186 REMARK 3 THROUGH 187 OR RESID 189 THROUGH 218 OR REMARK 3 RESID 220 OR RESID 222 THROUGH 268 OR REMARK 3 RESID 270 THROUGH 303 OR RESID 306 REMARK 3 THROUGH 307)) REMARK 3 SELECTION : (CHAIN E AND (RESID 184 OR RESID 186 REMARK 3 THROUGH 187 OR RESID 189 THROUGH 218 OR REMARK 3 RESID 220 OR RESID 222 THROUGH 268 OR REMARK 3 RESID 270 THROUGH 303 OR RESID 306 REMARK 3 THROUGH 307)) REMARK 3 ATOM PAIRS NUMBER : 660 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7KFK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1000252401. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28673 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.630 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 21.20 REMARK 200 R MERGE (I) : 0.20200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 16.90 REMARK 200 R MERGE FOR SHELL (I) : 1.30600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4LLA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS 8.3, 11% PEG3350, 1.1MM REMARK 280 AMSO4, 0.2MM LI2SO4, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.52200 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.52200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 76.06200 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.52200 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.52200 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 76.06200 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.52200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.52200 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 76.06200 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.52200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.52200 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 76.06200 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -46.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 429 REMARK 465 GLN A 430 REMARK 465 GLY A 431 REMARK 465 PRO A 432 REMARK 465 GLY A 433 REMARK 465 GLY A 434 REMARK 465 SER A 435 REMARK 465 ALA A 436 REMARK 465 TRP A 437 REMARK 465 SER A 438 REMARK 465 HIS A 439 REMARK 465 PRO A 440 REMARK 465 GLN A 441 REMARK 465 PHE A 442 REMARK 465 GLU A 443 REMARK 465 LYS A 444 REMARK 465 GLY A 445 REMARK 465 GLY A 446 REMARK 465 HIS A 447 REMARK 465 HIS A 448 REMARK 465 HIS A 449 REMARK 465 HIS A 450 REMARK 465 HIS A 451 REMARK 465 HIS A 452 REMARK 465 HIS A 453 REMARK 465 HIS A 454 REMARK 465 PHE B 429 REMARK 465 GLN B 430 REMARK 465 GLY B 431 REMARK 465 PRO B 432 REMARK 465 GLY B 433 REMARK 465 GLY B 434 REMARK 465 SER B 435 REMARK 465 ALA B 436 REMARK 465 TRP B 437 REMARK 465 SER B 438 REMARK 465 HIS B 439 REMARK 465 PRO B 440 REMARK 465 GLN B 441 REMARK 465 PHE B 442 REMARK 465 GLU B 443 REMARK 465 LYS B 444 REMARK 465 GLY B 445 REMARK 465 GLY B 446 REMARK 465 HIS B 447 REMARK 465 HIS B 448 REMARK 465 HIS B 449 REMARK 465 HIS B 450 REMARK 465 HIS B 451 REMARK 465 HIS B 452 REMARK 465 HIS B 453 REMARK 465 HIS B 454 REMARK 465 LYS E 173 REMARK 465 GLU E 174 REMARK 465 LEU E 175 REMARK 465 ALA E 176 REMARK 465 GLU E 177 REMARK 465 LYS E 178 REMARK 465 ALA E 179 REMARK 465 GLY E 180 REMARK 465 ALA E 181 REMARK 465 LEU E 182 REMARK 465 ALA E 183 REMARK 465 VAL E 309 REMARK 465 ALA E 310 REMARK 465 SER E 311 REMARK 465 ASP E 312 REMARK 465 LYS E 313 REMARK 465 THR E 314 REMARK 465 LEU E 315 REMARK 465 ALA E 316 REMARK 465 VAL E 317 REMARK 465 GLU E 318 REMARK 465 THR E 319 REMARK 465 ALA E 320 REMARK 465 LYS E 321 REMARK 465 LYS E 322 REMARK 465 GLN E 323 REMARK 465 LYS C 173 REMARK 465 GLU C 174 REMARK 465 LEU C 175 REMARK 465 ALA C 176 REMARK 465 GLU C 177 REMARK 465 LYS C 178 REMARK 465 ALA C 179 REMARK 465 GLY C 180 REMARK 465 LYS C 313 REMARK 465 THR C 314 REMARK 465 LEU C 315 REMARK 465 ALA C 316 REMARK 465 VAL C 317 REMARK 465 GLU C 318 REMARK 465 THR C 319 REMARK 465 ALA C 320 REMARK 465 LYS C 321 REMARK 465 LYS C 322 REMARK 465 GLN C 323 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 616 O HOH B 618 1.83 REMARK 500 O HOH B 615 O HOH B 618 1.84 REMARK 500 O HOH B 620 O HOH B 621 1.94 REMARK 500 O LYS E 280 O HOH E 501 1.98 REMARK 500 O LYS C 203 O HOH C 501 2.06 REMARK 500 ND2 ASN A 253 O HIS A 301 2.14 REMARK 500 O ASP B 264 O HOH B 601 2.17 REMARK 500 OD2 ASP C 219 OG1 THR C 221 2.17 REMARK 500 OE1 GLN A 347 NZ LYS A 377 2.19 REMARK 500 OH TYR C 223 O HOH C 502 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO E 190 CA - N - CD ANGL. DEV. = -11.3 DEGREES REMARK 500 LYS C 215 CA - CB - CG ANGL. DEV. = 18.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 260 45.74 36.91 REMARK 500 THR E 221 47.66 -85.02 REMARK 500 SER C 216 -16.42 77.54 REMARK 500 ASP C 219 -167.12 -102.02 REMARK 500 REMARK 500 REMARK: NULL DBREF1 7KFK A 222 421 UNP LIRB1-2_HUMAN DBREF2 7KFK A Q8NHL6-2 222 421 DBREF1 7KFK B 222 421 UNP LIRB1-2_HUMAN DBREF2 7KFK B Q8NHL6-2 222 421 DBREF 7KFK E 173 323 UNP C0H5N9 C0H5N9_PLAF7 173 323 DBREF 7KFK C 173 323 UNP C0H5N9 C0H5N9_PLAF7 173 323 SEQADV 7KFK GLY A 422 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY A 423 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY A 424 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK LEU A 425 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLU A 426 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK VAL A 427 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK LEU A 428 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK PHE A 429 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLN A 430 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY A 431 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK PRO A 432 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY A 433 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY A 434 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK SER A 435 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK ALA A 436 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK TRP A 437 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK SER A 438 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS A 439 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK PRO A 440 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLN A 441 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK PHE A 442 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLU A 443 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK LYS A 444 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY A 445 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY A 446 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS A 447 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS A 448 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS A 449 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS A 450 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS A 451 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS A 452 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS A 453 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS A 454 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY B 422 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY B 423 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY B 424 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK LEU B 425 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLU B 426 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK VAL B 427 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK LEU B 428 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK PHE B 429 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLN B 430 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY B 431 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK PRO B 432 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY B 433 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY B 434 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK SER B 435 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK ALA B 436 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK TRP B 437 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK SER B 438 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS B 439 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK PRO B 440 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLN B 441 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK PHE B 442 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLU B 443 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK LYS B 444 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY B 445 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLY B 446 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS B 447 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS B 448 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS B 449 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS B 450 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS B 451 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS B 452 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS B 453 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK HIS B 454 UNP Q8NHL6-2 EXPRESSION TAG SEQADV 7KFK GLN E 238 UNP C0H5N9 ASN 238 CONFLICT SEQADV 7KFK GLN E 323 UNP C0H5N9 ASN 323 CONFLICT SEQADV 7KFK GLN C 238 UNP C0H5N9 ASN 238 CONFLICT SEQADV 7KFK GLN C 323 UNP C0H5N9 ASN 323 CONFLICT SEQRES 1 A 233 VAL SER LYS LYS PRO SER LEU SER VAL GLN PRO GLY PRO SEQRES 2 A 233 ILE VAL ALA PRO GLU GLU THR LEU THR LEU GLN CYS GLY SEQRES 3 A 233 SER ASP ALA GLY TYR ASN ARG PHE VAL LEU TYR LYS ASP SEQRES 4 A 233 GLY GLU ARG ASP PHE LEU GLN LEU ALA GLY ALA GLN PRO SEQRES 5 A 233 GLN ALA GLY LEU SER GLN ALA ASN PHE THR LEU GLY PRO SEQRES 6 A 233 VAL SER ARG SER TYR GLY GLY GLN TYR ARG CYS TYR GLY SEQRES 7 A 233 ALA HIS ASN LEU SER SER GLU TRP SER ALA PRO SER ASP SEQRES 8 A 233 PRO LEU ASP ILE LEU ILE ALA GLY GLN PHE TYR ASP ARG SEQRES 9 A 233 VAL SER LEU SER VAL GLN PRO GLY PRO THR VAL ALA SER SEQRES 10 A 233 GLY GLU ASN VAL THR LEU LEU CYS GLN SER GLN GLY TRP SEQRES 11 A 233 MET GLN THR PHE LEU LEU THR LYS GLU GLY ALA ALA ASP SEQRES 12 A 233 ASP PRO TRP ARG LEU ARG SER THR TYR GLN SER GLN LYS SEQRES 13 A 233 TYR GLN ALA GLU PHE PRO MET GLY PRO VAL THR SER ALA SEQRES 14 A 233 HIS ALA GLY THR TYR ARG CYS TYR GLY SER GLN SER SER SEQRES 15 A 233 LYS PRO TYR LEU LEU THR HIS PRO SER ASP PRO LEU GLU SEQRES 16 A 233 LEU VAL VAL SER GLY GLY GLY GLY LEU GLU VAL LEU PHE SEQRES 17 A 233 GLN GLY PRO GLY GLY SER ALA TRP SER HIS PRO GLN PHE SEQRES 18 A 233 GLU LYS GLY GLY HIS HIS HIS HIS HIS HIS HIS HIS SEQRES 1 B 233 VAL SER LYS LYS PRO SER LEU SER VAL GLN PRO GLY PRO SEQRES 2 B 233 ILE VAL ALA PRO GLU GLU THR LEU THR LEU GLN CYS GLY SEQRES 3 B 233 SER ASP ALA GLY TYR ASN ARG PHE VAL LEU TYR LYS ASP SEQRES 4 B 233 GLY GLU ARG ASP PHE LEU GLN LEU ALA GLY ALA GLN PRO SEQRES 5 B 233 GLN ALA GLY LEU SER GLN ALA ASN PHE THR LEU GLY PRO SEQRES 6 B 233 VAL SER ARG SER TYR GLY GLY GLN TYR ARG CYS TYR GLY SEQRES 7 B 233 ALA HIS ASN LEU SER SER GLU TRP SER ALA PRO SER ASP SEQRES 8 B 233 PRO LEU ASP ILE LEU ILE ALA GLY GLN PHE TYR ASP ARG SEQRES 9 B 233 VAL SER LEU SER VAL GLN PRO GLY PRO THR VAL ALA SER SEQRES 10 B 233 GLY GLU ASN VAL THR LEU LEU CYS GLN SER GLN GLY TRP SEQRES 11 B 233 MET GLN THR PHE LEU LEU THR LYS GLU GLY ALA ALA ASP SEQRES 12 B 233 ASP PRO TRP ARG LEU ARG SER THR TYR GLN SER GLN LYS SEQRES 13 B 233 TYR GLN ALA GLU PHE PRO MET GLY PRO VAL THR SER ALA SEQRES 14 B 233 HIS ALA GLY THR TYR ARG CYS TYR GLY SER GLN SER SER SEQRES 15 B 233 LYS PRO TYR LEU LEU THR HIS PRO SER ASP PRO LEU GLU SEQRES 16 B 233 LEU VAL VAL SER GLY GLY GLY GLY LEU GLU VAL LEU PHE SEQRES 17 B 233 GLN GLY PRO GLY GLY SER ALA TRP SER HIS PRO GLN PHE SEQRES 18 B 233 GLU LYS GLY GLY HIS HIS HIS HIS HIS HIS HIS HIS SEQRES 1 E 151 LYS GLU LEU ALA GLU LYS ALA GLY ALA LEU ALA GLY GLU SEQRES 2 E 151 ALA ALA ARG ILE PRO ALA ALA ILE ASP ALA VAL ILE GLU SEQRES 3 E 151 GLY ILE LYS SER LYS PHE SER ILE ASP THR LEU GLY GLY SEQRES 4 E 151 GLU ALA LEU LYS SER VAL ILE ASP GLY THR ASN TYR TYR SEQRES 5 E 151 ASP ALA SER TYR ILE THR THR ALA ILE TYR ASN LYS PHE SEQRES 6 E 151 GLN VAL SER SER CYS LEU PRO SER VAL PRO PHE LEU GLY SEQRES 7 E 151 GLY PRO PRO VAL PRO GLY ALA GLY ALA ASN LYS PRO ILE SEQRES 8 E 151 CYS SER ALA VAL ASP LYS LEU TYR LEU GLY SER GLY ASN SEQRES 9 E 151 PHE LEU ASP LYS SER SER LEU PRO GLY SER ILE GLN LYS SEQRES 10 E 151 ASP VAL ALA LYS ILE VAL ALA GLY ALA GLU GLN ALA ALA SEQRES 11 E 151 LYS ALA LYS ALA ALA MET VAL ALA SER ASP LYS THR LEU SEQRES 12 E 151 ALA VAL GLU THR ALA LYS LYS GLN SEQRES 1 C 151 LYS GLU LEU ALA GLU LYS ALA GLY ALA LEU ALA GLY GLU SEQRES 2 C 151 ALA ALA ARG ILE PRO ALA ALA ILE ASP ALA VAL ILE GLU SEQRES 3 C 151 GLY ILE LYS SER LYS PHE SER ILE ASP THR LEU GLY GLY SEQRES 4 C 151 GLU ALA LEU LYS SER VAL ILE ASP GLY THR ASN TYR TYR SEQRES 5 C 151 ASP ALA SER TYR ILE THR THR ALA ILE TYR ASN LYS PHE SEQRES 6 C 151 GLN VAL SER SER CYS LEU PRO SER VAL PRO PHE LEU GLY SEQRES 7 C 151 GLY PRO PRO VAL PRO GLY ALA GLY ALA ASN LYS PRO ILE SEQRES 8 C 151 CYS SER ALA VAL ASP LYS LEU TYR LEU GLY SER GLY ASN SEQRES 9 C 151 PHE LEU ASP LYS SER SER LEU PRO GLY SER ILE GLN LYS SEQRES 10 C 151 ASP VAL ALA LYS ILE VAL ALA GLY ALA GLU GLN ALA ALA SEQRES 11 C 151 LYS ALA LYS ALA ALA MET VAL ALA SER ASP LYS THR LEU SEQRES 12 C 151 ALA VAL GLU THR ALA LYS LYS GLN HET NAG A 501 14 HET NAG A 502 14 HET NAG A 503 14 HET NAG B 501 14 HET NAG B 502 14 HET NAG B 503 14 HET SO4 B 504 5 HET SO4 B 505 5 HET SO4 B 506 5 HET SO4 E 401 5 HET SO4 C 401 5 HET SO4 C 402 5 HET SO4 C 403 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM SO4 SULFATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 5 NAG 6(C8 H15 N O6) FORMUL 11 SO4 7(O4 S 2-) FORMUL 18 HOH *55(H2 O) HELIX 1 AA1 SER A 288 GLY A 292 5 5 HELIX 2 AA2 THR A 388 ALA A 392 5 5 HELIX 3 AA3 SER B 288 GLY B 292 5 5 HELIX 4 AA4 THR B 388 ALA B 392 5 5 HELIX 5 AA5 GLU E 185 PHE E 204 1 20 HELIX 6 AA6 ASP E 207 ASP E 219 1 13 HELIX 7 AA7 ASP E 225 GLN E 238 1 14 HELIX 8 AA8 VAL E 239 LEU E 243 5 5 HELIX 9 AA9 LYS E 261 LEU E 272 1 12 HELIX 10 AB1 SER E 281 MET E 308 1 28 HELIX 11 AB2 LEU C 182 PHE C 204 1 23 HELIX 12 AB3 ASP C 207 LYS C 215 1 9 HELIX 13 AB4 ASP C 225 GLN C 238 1 14 HELIX 14 AB5 VAL C 239 LEU C 243 5 5 HELIX 15 AB6 LYS C 261 LEU C 272 1 12 HELIX 16 AB7 SER C 281 ASP C 312 1 32 SHEET 1 AA1 3 SER A 227 GLN A 231 0 SHEET 2 AA1 3 THR A 243 SER A 248 -1 O GLN A 245 N SER A 229 SHEET 3 AA1 3 SER A 278 THR A 283 -1 O ALA A 280 N CYS A 246 SHEET 1 AA2 6 ILE A 235 VAL A 236 0 SHEET 2 AA2 6 LEU A 314 ILE A 318 1 O LEU A 317 N VAL A 236 SHEET 3 AA2 6 GLY A 293 ALA A 300 -1 N GLY A 293 O ILE A 316 SHEET 4 AA2 6 ARG A 254 LYS A 259 -1 N TYR A 258 O ARG A 296 SHEET 5 AA2 6 GLN A 267 GLY A 270 -1 O ALA A 269 N PHE A 255 SHEET 6 AA2 6 PHE E 277 LEU E 278 -1 O LEU E 278 N LEU A 268 SHEET 1 AA3 4 VAL A 326 VAL A 330 0 SHEET 2 AA3 4 ASN A 341 SER A 348 -1 O GLN A 347 N SER A 327 SHEET 3 AA3 4 LYS A 377 PRO A 386 -1 O PHE A 382 N LEU A 344 SHEET 4 AA3 4 THR A 372 GLN A 374 -1 N THR A 372 O GLN A 379 SHEET 1 AA4 6 THR A 335 VAL A 336 0 SHEET 2 AA4 6 GLY A 423 VAL A 427 -1 O GLY A 424 N VAL A 336 SHEET 3 AA4 6 LEU A 415 SER A 420 -1 N SER A 420 O GLY A 423 SHEET 4 AA4 6 GLY A 393 SER A 400 -1 N GLY A 393 O LEU A 417 SHEET 5 AA4 6 THR A 354 LYS A 359 -1 N THR A 358 O ARG A 396 SHEET 6 AA4 6 TRP A 367 ARG A 370 -1 O LEU A 369 N PHE A 355 SHEET 1 AA5 3 SER B 227 GLN B 231 0 SHEET 2 AA5 3 LEU B 242 SER B 248 -1 O THR B 243 N GLN B 231 SHEET 3 AA5 3 SER B 278 LEU B 284 -1 O LEU B 284 N LEU B 242 SHEET 1 AA6 6 ILE B 235 VAL B 236 0 SHEET 2 AA6 6 LEU B 314 ILE B 318 1 O LEU B 317 N VAL B 236 SHEET 3 AA6 6 GLY B 293 ALA B 300 -1 N GLY B 293 O ILE B 316 SHEET 4 AA6 6 ARG B 254 LYS B 259 -1 N TYR B 258 O ARG B 296 SHEET 5 AA6 6 GLN B 267 GLY B 270 -1 O ALA B 269 N PHE B 255 SHEET 6 AA6 6 PHE C 277 LEU C 278 -1 O LEU C 278 N LEU B 268 SHEET 1 AA7 4 SER B 327 VAL B 330 0 SHEET 2 AA7 4 ASN B 341 SER B 348 -1 O LEU B 345 N SER B 329 SHEET 3 AA7 4 LYS B 377 PRO B 386 -1 O PHE B 382 N LEU B 344 SHEET 4 AA7 4 THR B 372 GLN B 374 -1 N THR B 372 O GLN B 379 SHEET 1 AA8 6 THR B 335 VAL B 336 0 SHEET 2 AA8 6 GLY B 423 VAL B 427 -1 O GLY B 424 N VAL B 336 SHEET 3 AA8 6 LEU B 415 SER B 420 -1 N SER B 420 O GLY B 423 SHEET 4 AA8 6 GLY B 393 SER B 400 -1 N GLY B 393 O LEU B 417 SHEET 5 AA8 6 THR B 354 LYS B 359 -1 N THR B 358 O ARG B 396 SHEET 6 AA8 6 TRP B 367 ARG B 370 -1 O LEU B 369 N PHE B 355 SSBOND 1 CYS A 246 CYS A 297 1555 1555 2.04 SSBOND 2 CYS A 346 CYS A 397 1555 1555 2.03 SSBOND 3 CYS B 246 CYS B 297 1555 1555 2.04 SSBOND 4 CYS B 346 CYS B 397 1555 1555 2.04 SSBOND 5 CYS E 242 CYS E 264 1555 1555 2.03 SSBOND 6 CYS C 242 CYS C 264 1555 1555 2.03 LINK ND2 ASN A 281 C1 NAG A 503 1555 1555 1.45 LINK ND2 ASN A 302 C1 NAG A 501 1555 1555 1.43 LINK ND2 ASN A 341 C1 NAG A 502 1555 1555 1.44 LINK ND2 ASN B 281 C1 NAG B 503 1555 1555 1.44 LINK ND2 ASN B 302 C1 NAG B 501 1555 1555 1.44 LINK ND2 ASN B 341 C1 NAG B 502 1555 1555 1.45 CISPEP 1 GLN A 231 PRO A 232 0 3.74 CISPEP 2 GLN B 231 PRO B 232 0 5.02 CRYST1 111.044 111.044 152.124 90.00 90.00 90.00 P 42 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009005 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009005 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006574 0.00000